Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Toronto

$105,000.00

Associated risk factors and genetic variants for incident autoimmune disorders following SARS-CoV-2 infection in adults in Ontario

FY 2023-24

Summary
Long COVID affects an estimated 10% to 70% of individuals who contract the COVID-19 virus. It affects multiple systems in the body, causing symptoms such as cough, fever, and depression. A recent study on those with a history of COVID-19 found increased risks of several autoimmune disorders compared to those without a history of COVID-19. Studies investigating the causes of autoimmune disorders have uncovered complex underlying causes including genetic predispositions and environmental triggers. Research has shown that under normal conditions the age of onset for autoimmune disorders varies heavily between types and within types. Studies have also shown clear differences in the rates of most autoimmune disorders by sex, with females predominantly affected. This study will: 1) Determine the incidence of new onset of rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), Guillain-Barré syndrome (GBS), and/or psoriasis (Psa) following a COVID-19 infection among adults in Ontario; 2) Investigate the impact of age by sex on new onset RA, SLE, GBS, and/or Psa following a COVID-19 infection among adults in Ontario; and 3) Identify genetic variants associated with autoimmune symptoms of long COVID among adults in Ontario. This study will use Ontario health administration data available through ICES and genetic data from the Canadian COVID Genomics Network (CanCOGeN) HostSeq. With no known cause of long COVID it is extremely important to provide context to this condition. Thus, this research will be a crucial step in helping to demystify the risk factors surrounding long COVID autoimmune disorders. This study may also identify individuals at risk for autoimmune disorders post COVID-19 infection, allowing targeted interventions and treatments to be developed. This would also provide the evidence needed for the conduct of more studies with long-term follow-up or investigating mechanisms of long COVID.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
496568
Name
Grima Alicia A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Doctoral Research Awards - B
Projecttitle
Associated risk factors and genetic variants for incident autoimmune disorders following SARS-CoV-2 infection in adults in Ontario
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Autoimmune Disorder Post Covid-19 Infection; Genome-Wide Association Study (Gwas); Log-Binomial Model; Post-Viral Syndrome Or Long Covid; Risk Factors; Risk Ratios; Sars-Cov-2 Or Covid-19
Abstract
Long COVID affects an estimated 10% to 70% of individuals who contract the COVID-19 virus. It affects multiple systems in the body, causing symptoms such as cough, fever, and depression. A recent study on those with a history of COVID-19 found increased risks of several autoimmune disorders compared to those without a history of COVID-19. Studies investigating the causes of autoimmune disorders have uncovered complex underlying causes including genetic predispositions and environmental triggers. Research has shown that under normal conditions the age of onset for autoimmune disorders varies heavily between types and within types. Studies have also shown clear differences in the rates of most autoimmune disorders by sex, with females predominantly affected. This study will: 1) Determine the incidence of new onset of rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), Guillain-Barré syndrome (GBS), and/or psoriasis (Psa) following a COVID-19 infection among adults in Ontario; 2) Investigate the impact of age by sex on new onset RA, SLE, GBS, and/or Psa following a COVID-19 infection among adults in Ontario; and 3) Identify genetic variants associated with autoimmune symptoms of long COVID among adults in Ontario. This study will use Ontario health administration data available through ICES and genetic data from the Canadian COVID Genomics Network (CanCOGeN) HostSeq. With no known cause of long COVID it is extremely important to provide context to this condition. Thus, this research will be a crucial step in helping to demystify the risk factors surrounding long COVID autoimmune disorders. This study may also identify individuals at risk for autoimmune disorders post COVID-19 infection, allowing targeted interventions and treatments to be developed. This would also provide the evidence needed for the conduct of more studies with long-term follow-up or investigating mechanisms of long COVID.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Grima, Alicia A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~